Martin Moylan Feature Archive

Shares of St. Jude Medical rose 5 percent to close at $50 Wednesday, as the company reported earnings and revenue that were higher than expected. (07/17/2013)
Medtronic is alerting customers to two problems with its insulin pumps. (07/12/2013)
The Minneapolis-based megabank, which still runs under the Lincoln charter, is marking its 150th anniversary this week. (07/12/2013)
Nearly 20 retailers, including Target and Walmart, have unveiled a plan for improving worker safety in Bangladeshi garment factories. (07/10/2013)
A proposed flour milling joint venture of Cargill, CHS and ConAgra is drawing attention from the federal government. (07/05/2013)
Best Buy shares jumped up 9 percent today to nearly $30. (07/01/2013)
A key economic measure from Creighton University indicates manufacturers in Minnesota continue to expect growth in coming months, but perhaps more slowly than last year. (07/01/2013)
Travel experts say a big fine levied on Delta Air Lines shows that consumers should be familiar with airline bumping rules to protect themselves. Federal regulators recently fined Delta $750,000 for involuntarily bumping passengers from overbooked flights. (06/30/2013)
The fallout builds from revelations that the Southern celebrity chef used racial slurs in the past. Diabetes drug maker Novo Nordisk also joined the companies distancing themselves from her. (06/27/2013)
General Mills' is reporting that quarterly earnings rose 13 percent to $366 million. But the food company lowered its earnings forecast slightly for its coming fiscal year, citing higher costs. (06/26/2013)
Medtronic is warning patients and doctors about several problems with the company's SynchroMed implantable medication pumps. (06/26/2013)
Doctors are reporting a major step toward an "artificial pancreas," a device made by Medtronic that would constantly monitor blood sugar in people with diabetes and automatically supply insulin as needed. (06/24/2013)
A Twin Cities firm that is also a leader in the 3-D printing industry is buying a major competitor. (06/19/2013)
Minnesota has one of the fastest-growing economies in the country, says a study by the U.S Bureau of Economic Analysis. (06/17/2013)
Medtronic's Infuse bone-grafting product has long been beset by controversy. Questions have been raised about its effectiveness, as well as the integrity of Medtronic-funded scientific studies evaluating the product. Reviews of Medtronic's Infuse product have found it provides little to no benefit compared with more typical treatments. (06/17/2013)